Shares of Novo Nordisk, the fourth-largest healthcare company on the STOXX index, climbed 3.1% after the company said Wegovy cut the risk of heart attack, stroke or death by 57% versus Eli Lilly’s rival medicines Mounjaro and Zepbound in a real-world comparison.
European stocks rise as Novo Nordisk lifts healthcare on Wegovy data
September 1, 2025
Recent Post
ARC Insulation IPO allotment date likely today. GMP, steps to check share allotment status online
August 26, 2025
Stock market holiday: Is the Indian stock market open or closed on Ganesh Chaturthi 2025?
August 26, 2025
Japan’s Nikkei ends at over 2-week low as yen gains after Trump fires Fed’s Cook
August 26, 2025
Have Any Question?
Do not hesitate to contact us. We’re a team of experts ready to talk to you.
